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OBJECTIVE. To determine rates of blood culture contamination comparing 3 strategies to prevent intensive care unit (ICU) 
infections: screening and isolation, targeted decolonization, and universal decolonization. 
 
DESIGN. Pragmatic cluster-randomized trial. 
 
SETTING. Forty-three hospitals with 74 ICUs; 42 of 43 were community hospitals. 
 
PATIENTS. Patients admitted to adult ICUs from July 1, 2009, to September 30, 2011. 
 
METHODS. After a 6-month baseline period, hospitals were randomly assigned to 1 of 3 strategies, with all participating adult ICUs 
in a given hospital assigned to the same strategy. Arm 1 implemented methicillin-resistant Staphylococcus aureus (MRSA) nares 
screening and isolation, arm 2 targeted decolonization (screening, isolation, and decolonization of MRSA carriers), and arm 3 
conducted no screening but universal decolonization of all patients with mupirocin and chlorhexidine (CHG) bathing. Blood culture 
contamination rates in the intervention period were compared to the baseline period across all 3 arms. 
 
RESULTS. During the 6-month baseline period, 7,926 blood cultures were collected from 3,399 unique patients: 1,099 sets in arm 1, 
928 in arm 2, and 1,372 in arm 3. During the 18-month intervention period, 22,761 blood cultures were collected from 9,878 unique 
patients: 
3,055 sets in arm 1, 3,213 in arm 2, and 3,610 in arm 3. Among all individual draws, for arms 1, 2, and 3, the contamination rates 
were 4.1%, 3.9%, and 3.8% for the baseline period and 3.3%, 3.2%, and 2.4% for the intervention period, respectively. When we 
evaluated sets of blood cultures rather than individual draws, the contamination rate in arm 1 (screening and isolation) was 9.8% (JV 
= 108 sets) in the baseline period and 7.5% (N = 228) in the intervention period. For arm 2 (targeted decolonization), the baseline rate 
was 8.4% (JV = 78) compared to 7.5% (JV = 241) in the intervention period. Arm 3 (universal decolonization) had the greatest 
decrease in contamination rate, with a decrease from 8.7% (JV = 119) contaminated blood cultures during the baseline period to 
5.1% (JV = 184) during the intervention period. Logistic regression models demonstrated a significant difference across the arms 
when comparing the reduction in contamination between baseline and intervention periods in both unadjusted (P = .02) and adjusted 
(P = .02) analyses. Arm 3 resulted in the greatest reduction in blood culture contamination rates, with an unadjusted odds ratio (OR) 
of 0.56 (95% confidence interval [CI], 0.044-0.71) and an adjusted OR of 0.55 (95% CI, 0.43-0.71). 
 
CONCLUSION. In this large cluster-randomized trial, we demonstrated that universal decolonization with CHG bathing resulted in a 
significant reduction in blood culture contamination. 
 
 
 
Blood cultures are a critical tool to diagnose bacteremia and guide antimicrobial therapy, especially with the 
increasing threat of multidrug-resistant organisms (MDROs). However, contamination  of  blood cultures is 
still a common problem and  may represent  up to half of all positive blood  cult ures.1• 2 The Clinical and 
Laboratory Standards Institute recommends that each facility maintain a contamination rate less than 3%.3 The  
American  Society  for  Microbiology's and  College of American Pathologists' benchmark for contaminated 
blood cultures hospital wide is between 2.5% and 3%.4,5 In recent studies the overall blood culture 
contamination rate in intensive care unit (ICU) populations ranged from 4% to 
5.5%.6'7 "Contamination" in these reports is defined as the number of contaminated blood cultures divided by 
the total number of blood culture draws multiplied by 100. Contamination can lead to unnecessary 
antimicrobial therapy, unnecessary removal of central lines, unnecessary testing, increased length of stay, and 
increased cost. Bates et al8 estimated the cost of contaminated blood cultures at $4,500 per episode. Patients 
with contaminated blood cultures are just as likely to receive antimicrobial therapy as patients with true 
bacteremia.9 It has been reported that up to half of patients with false-positive blood cultures for coagulase-
negative staphylococci were treated with antibiotics, usually vancomycin, with an estimated additional cost of 
approximately $1,000 per patient.10 This association between contaminated blood cultures and unnecessary 
antibiotic use, additional laboratory tests, and increased hospital length of stay and excess costs has been 
confirmed in subsequent studies, with costs as high as $10,000.1112 
Contamination of percutaneous blood cultures is thought to be due to the introduction of organisms from the 
skin of the patient into the collected sample.13 Inadequate preparation of the skin is thought to be the most 
common cause of blood culture contamination.14 This is supported by surveys of the most common organisms 
in contaminated blood cultures, which represent organisms that are known to be present on the skin of 
hospitalized patients. The most common contaminant is coagulase-negative staphylococci, which accounts for 
approximately 75% of contaminated blood cultures, followed by Propionibacterium sp., Micrococcus sp., 
Corynebacterium sp., Bacillus sp. (not Bacillus anthracis), Micrococcus sp., viridans streptococci, and 7-
hemolytic streptococci (not Enterococcus sp.).4'9'15 Accordingly, interventions that have been studied to 
reduce contamination are those that could reduce skin bacterial load or reduce the likelihood of inadvertent 
introduction of skin contaminants into the sample. These include disinfection methods for skin preparation, 
culture bottle preparation, needle exchange for bottle inoculation, limiting the use of blood drawn from 
intravenous lines, and the use of dedicated phlebotomy teams.4 Recently, several studies have suggested that 
chlorhexidine (CHG) bathing of patients in the ICU may reduce blood culture contamination 
rates.1618 
In our previous publication,19 we reported that universal decolonization was more effective than targeted 
decolonization or screening and isolation in reducing methicillin-resistant Staphylococcus aureus (MRSA) 
clinical cultures and bloodstream infections from any pathogen. In this study, we investigated whether these 3 
strategies to prevent ICU infections would have an effect on the rates of blood culture contamination. 
 
METHODS 
 
Study Design 
 
The Randomized Evaluation of Decolonization vs Universal Clearance to Eradicate MRSA (REDUCE MRSA) 
trial was a 3-arm cluster-randomized trial of hospitals in the Hospital Corporation of America (HCA) system. 
This study compared 3 strategies to decrease MRSA infections in adult ICUs. Elements of the trial design have 
been previously described.17 The strategies were limited to the adult ICU and included: 
• Arm 1: Screening and isolation: Patients received bilateral nares screening for MRSA upon ICU admission. 
Contact precautions were employed for patients with a known history of MRSA (either colonization or 
infection) or a current culture or screening test positive for MRSA. This arm was considered standard of care at 
the time and in practice since 2007.18 
• Arm 2: Targeted decolonization: At ICU admission, patients received MRSA screening and contact 
precautions similar to arm 1. Patients with known MRSA colonization received decolonization with twice 
daily intranasal 2% mupirocin ointment and daily 2% CHG cloth baths for 5 days. 
• Arm 3: Universal decolonization: There was no screening for MRSA at ICU admission. Contact precautions 
similar to arm 1 were employed. All ICU patients received twice daily intranasal mupirocin ointment for 5 
days plus daily 2% CHG cloth baths for the entire duration of their ICU stay.  
 
This study consisted of a 6 month baseline period from July 1 to December 31, 2009; a phase-in period 
from January 1 to April 7, 2010; and an 18-month intervention period from April 8, 2010, to September 30, 
2011. This study was approved by the Harvard Pilgrim Health Care institutional review board. 
 
Determination of Blood Culture Contamination 
 
For descriptive purposes, we provide the percent of all blood culture draws either by a percutaneous (direct 
skin puncture) or from an existing intravascular catheter that contained a skin commensal consistent with 
contamination. The performance of an individual blood culture commonly involves collecting a volume of 
blood either via venipuncture or from an intravascular catheter and distributing it into 1 or more bottles (eg, an 
aerobic and anaerobic bottle). However, in keeping with clinical application, all analyses were performed at the 
level of blood culture sets unless otherwise specified. Blood culture sets were eligible for the determination of 
contamination  if at least 2 ICU-attributed blood cultures were drawn within 2 calendar days of one another. 
Thus, a single blood culture draw within a 2-day period was excluded from evaluation. Two or more blood 
cultures during that time window constituted a single set. Only the first eligible set per patient was evaluated. 
Blood cultures were deemed attributable to the ICU if the draws occurred more than 1 day into the ICU stay 
through the day of ICU discharge. This attribution window was selected to allow for the first CHG bath to be 
given in the ICU. We were unable to determine accurately which blood cultures were drawn by venipuncture 
or from an existing line. 
Among eligible blood culture sets, contamination was defined as having 1 or more of the following 
pathogens isolated from only 1 blood culture within the set: coagulase-negative Staphylococcus sp., 
Lactobacillus sp., Propionibacterium acnes, Corynebacterium sp., Bacillus sp. (not B. anthracis), Micrococcus 
sp., viridans streptococci, and 7-hemolytic streptococci (not Enterococcus sp.). Our analysis focuses on the 
proportion of eligible blood culture sets that had a contamination event across all 3 study arms. 
 
 
 
 
Statistical Analysis 
 
Census and microbiologic information were obtained from the HCA centralized clinical electronic data 
warehouse. The HCA system uses a single electronic health record (EHR) platform including the microbiology 
module for test orders and resulting. The contamination rate was calculated as a percentage of eligible blood  
culture sets. 
We used generalized linear mixed models to account for the cluster-randomized design of the trial. In that 
context, we used logistic regression to assess the treatment arm, period, and arm-by-period interaction effect. 
The 2-degree-of-freedom test assessing the interaction addresses the null hypothesis that the change from 
baseline to intervention period was the same in each arm. Sensitivity analysis included multivariable covariate-
adjusted models that accounted for age, sex, race, insurance type, coexisting conditions, and surgery during the 
hospital stay. Analyses were performed with use of Statistical Analysis System (SAS) software, version 9.3 
(SAS Institute).  
 
RESULTS 
Patient characteristics were similar across all groups and between baseline and intervention periods (Table 1). 
During the 6-month baseline period, 7,926 blood cultures were collected from 3,399 unique patients: 1,099 sets 
in arm 1, 928 in arm 2, and 1,372 in arm 3. During the 18-month intervention period, 22,761 blood cultures 
were collected from 9,878 unique patients: 3,055 sets in arm 1, 3,213 in arm 2, and 3,610 in arm 3. Among all 
individual draws, for arms 1, 2, and 3, the contamination rates were 4.1%, 3.9%, and 3.8% for the baseline 
period and 3.3%, 3.2%, and 2.4% for the intervention period, respectively. 
When we evaluated sets of blood cultures rather than individual draws, the contamination rate in arm 1 
(screening and isolation) was 9.8% (N = 108 sets) in the baseline period and 7.5% (N = 228) in the intervention 
period. For arm 2 (targeted decolonization), the baseline rate was 8.4% (N = 78) compared to 7.5% (N = 241) 
in the intervention period. Arm 3 (universal decolonization) had the greatest decrease in contamination rate, 
with a decrease from 8.7% (N = 119) contaminated blood cultures during the baseline period to 5.1% (N = 
184) during the intervention period.  
Logistic regression models for contaminated sets (Table 2) demonstrated a significant difference across the 
arms when comparing the reduction in contamination between baseline and intervention periods in both 
unadjusted (P = .02) and adjusted (P = .02) analyses. All arms showed a reduction in contamination between 
the intervention period and the baseline period, but universal decolonization resulted in the greatest reduction 
in blood culture contamination rates, with an unadjusted odds ratio (OR) of 0.56 (95% confidence interval 
[CI], 0.044-0.71) and an adjusted OR of 0.55 (95% CI, 0.43-0.71). P values in the pairwise analysis were as 
follows: P = .19 for the comparison of arm 2 with arm 1, P = .11 for the comparison of arm 3 with arm 1, and 
P = .005 for the comparison of arm 3 with arm 2. Based on the ORs, universal decolonization avoided an 
additional 26.8 contaminated blood culture sets per 1,000 admissions compared to arm 2 and an additional 12.2 
contaminated blood culture sets per 1,000 admissions compared to arm 1. The most common organism 
associated with contamination was coagulase-negative Staphylococcus sp. (85.0%), followed by Streptococcus 
sp. (6.4%) and Bacillus sp. (3.0%; Table 3).  
 
DISCUSSION 
 
Contamination of blood cultures can alter the course of a patient's treatment, resulting in outcomes such as 
inappropriate antibiotic use, longer hospital stays, or increased cost. Evidence suggests that the rate of blood 
culture contamination could potentially be influenced by interventions that decrease skin bacterial load, such as 
CHG bathing. 
Bleasdale et al16 examined the effectiveness of CHG bathing to reduce central line-associated bloodstream 
infections (CLABSIs) in a 2-ICU crossover study. They reported a significant reduction in primary BSIs and a 
nonsignificant reduction in the incidence of blood culture contamination from 4.3 to 1.8 per 1,000 patient-days. 
Popovich et al17'18 have reported significant declines in blood culture contamination rates in both medical 
 
 
 
ICUs (6.99 to 4.1 per 1,000 patient-days) and surgical ICUs (5.97 to 2.41 per 1,000 patient-days). 
In this large cluster-randomized trial, we demonstrated that universal decolonization with CHG bathing 
resulted in a significant reduction in blood culture contamination. Of interest the 45% reduction in blood 
culture contamination with universal decolonization is virtually identical to the 44% reduction of all cause 
bloodstream infections previously reported.19 
In this study, we observed a decrease in blood culture contamination in all arms of the study, suggesting a 
secular trend despite the comprehensive efforts to prevent competing interventions during the trial.19 While we 
inquired monthly about competing interventions and participating hospitals were instructed to bring any 
product or practice changes before the study steering committee, it is possible that national attention to skin or 
line connector preparation prior to phlebotomy, national efforts to support drawing blood by venipuncture 
whenever possible, and the concept of dedicated phlebotomy teams may have had a secular impact. 
Almost all HCA facilities track blood culture contamination rates as a quality indicator, with appropriate 
action taken when rates are determined to be greater than 3% after blood culture draws. This included 
reeducation along retraining healthcare professionals' skills on specimen collection and limiting use of blood 
draws from intravenous lines. Also, to address national guidance for best practice, HCA launched a campaign 
as part of a patient safety initiative to reduce CLABSIs, emphasizing maintenance of lines including 
"scrubbing the hub" and standardizing connectors to meet certain design and safety criteria, making it easier to 
adequately disinfect the hub. This initiative was equally applied across all 3 arms. This initiative, along with 
tracking contamination rates, probably explains the secular trend noted in this analysis. 
We believe that the benefit attributable to universal decolonization (arm 3) relates to reducing patient 
bioburden by reducing skin colonization20 since inadequate skin preparation is thought to be the most 
common cause of blood culture contamination.413 In addition, our protocol included not only cleaning of the 
skin with 2% CHG cloths but also wiping of the proximal 6 inches of the line, including the connectors and 
hubs, with 2% CHG cloths. Coagulase-negative Staphylococcus sp. was the most common contaminant in our 
trial, consistent with other publications.4,915  
The strength of our study was the large size and rigorous design as a pragmatic comparative effectiveness 
trial implemented primarily through the hospital processes. This design was chosen so that the implementation 
could be generalized to the broadest set of hospitals with available resources. Our study, however, had several 
limitations. Since microbiologic data were captured through our early clinical data warehouse, we were not 
then able to capture clinical signs or symptoms that could be associated with a clinical infection. In addition we 
were unable to account for the method of blood draw, including the method of skin cleaning and whether blood 
cultures were taken peripherally or from an existing line. However, such differences across groups are largely 
accounted for by comparing the outcome rate in each hospital with that hospital's baseline rate, providing 
reassurance that the benefit is attributable to decolonization rather than to baseline variation in case-mix or 
clinical practices across groups. 
In conclusion, our study, along with other studies, clearly demonstrated that CHG bathing has a role in 
decreasing blood culture contamination rates. As this study showed, interventions targeted at different 
outcomes, such as the reduction of bloodstream infections, can also drive improvements in the rate of blood 
culture contaminations. Reduction of blood culture contamination can improve the quality of blood culture 
results and can prevent unnecessary antibiotics, decrease cost, and decrease length of stay.  
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